In a notable insider transaction, Christopher Boerner, CEO of Bristol-Myers Squibb Co (NYSE:BMY), has recently increased his stake in the company.
Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie are included in this Analyst Blog.
Regulatory and pipeline updates from Avidity Biosciences, Inc. (RNA) and BioVie (BIVI) are in the spotlight this week.